Mail

UK markets closed

FTSE 100
8,433.76
+52.41(+0.63%)
FTSE 250
20,645.38
+114.08(+0.56%)
AIM
789.87
+6.17(+0.79%)
GBP/EUR
1.1622
+0.0011(+0.09%)
GBP/USD
1.2525
+0.0001(+0.01%)
Bitcoin GBP
48,976.93
+221.29(+0.45%)

Family-run Stilton maker on Brexit and copycats

'We want people to eat more cheese for breakfast'

MediPharm Labs Corp. (MLZ.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR

Add to watchlist

0.0510

-0.0032

(-5.90%)

At close: 08:18AM CEST

Currency in EUR

Valuation measures⁴

Market cap (intra-day)	21.92M
Enterprise value	11.28M
Trailing P/E	186.75
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.83
Price/book (mrq)	0.57
Enterprise value/revenue	0.41
Enterprise value/EBITDA	-0.93

Trading information

Stock price history

Beta (5Y monthly)	0.91
52-week change ³	0.20%
S&P500 52-week change ³	26.27%
52-week high ³	0.0700
52-week low ³	0.0303
50-day moving average ³	0.0492
200-day moving average ³	0.0457

Share statistics

Avg vol (3-month) ³	1.14k
Avg vol (10-day) ³	4.34k
Shares outstanding ⁵	404.05M
Implied shares outstanding ⁶	429.82M
Float ⁸	386.6M
% held by insiders ¹	2.47%
% held by institutions ¹	0.72%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	-39.57%
Operating margin (ttm)	37.76%

Management effectiveness

Return on assets (ttm)	-12.01%
Return on equity (ttm)	-24.00%

Income statement

Revenue (ttm)	33.06M
Revenue per share (ttm)	0.09
Quarterly revenue growth (yoy)	62.60%
Gross profit (ttm)	N/A
EBITDA	-10.03M
Net income avi to common (ttm)	-13.08M
Diluted EPS (ttm)	-0.0300
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	18.25M
Total cash per share (mrq)	0.05
Total debt (mrq)	2.29M
Total debt/equity (mrq)	4.33%
Current ratio (mrq)	3.37
Book value per share (mrq)	0.13

Cash flow statement

Operating cash flow (ttm)	-12.34M
Levered free cash flow (ttm)	-95.75k